Johnson & Johnson to fall short of 10 million vaccine doses promised by end of February - CBS News

Johnson & Johnson expects to fall far short of its commitment to deliver 10 million doses of its COVID-19 vaccine by the end of February, with under 4 million to be ready to ship after a hoped-for emergency use authorization from the Food and Drug Administration. .

Johnson & Johnson promised to deliver another 25 million by the end of March.

"We will have 20 million doses of the vaccine to be made available by the end of March and we're prepared to ship, immediately upon emergency use authorization, nearly 4 million doses of our vaccine," Dr.

He said the company remains "confident in our plans to deliver 100 million" doses by the end of June.

As a single-dose vaccine that can be stored at standard refrigerator temperatures for three months, Johnson & Johnson's candidate had been heralded as a key advance in the U.S.

Last year, states were given specific allocations of both Pfizer and Moderna's vaccine weeks ahead of the FDA's authorization.

By comparison, before this week Biden administration officials had declined to provide a specific number of doses they expected from Johnson & Johnson, much less what allocations the states should expect